Drug precipitation inhibitors in supersaturable formulations
S Xu, WG Dai - International journal of pharmaceutics, 2013 - Elsevier
Use of supersaturable formulations has been demonstrated as an effective approach to
improve solubility and oral absorption of poorly water-soluble compounds. In supersaturable …
improve solubility and oral absorption of poorly water-soluble compounds. In supersaturable …
Approaches to increase mechanistic understanding and aid in the selection of precipitation inhibitors for supersaturating formulations–a PEARRL review
DJ Price, F Ditzinger, NJ Koehl… - Journal of Pharmacy …, 2019 - academic.oup.com
Objectives Supersaturating formulations hold great promise for delivery of poorly soluble
active pharmaceutical ingredients (APIs). To profit from supersaturating formulations …
active pharmaceutical ingredients (APIs). To profit from supersaturating formulations …
Current status of supersaturable self-emulsifying drug delivery systems
Self-emulsifying drug delivery systems (SEDDSs) are a vital strategy to enhance the
bioavailability (BA) of formulations of poorly water-soluble compounds. However, these …
bioavailability (BA) of formulations of poorly water-soluble compounds. However, these …
Supersaturation-based drug delivery systems: strategy for bioavailability enhancement of poorly water-soluble drugs
A Sharma, K Arora, H Mohapatra, RK Sindhu, M Bulzan… - Molecules, 2022 - mdpi.com
At present, the majority of APIs synthesized today remain challenging tasks for formulation
development. Many technologies are being utilized or explored for enhancing solubility …
development. Many technologies are being utilized or explored for enhancing solubility …
Chitosan-ricobendazole complex: Synthesis, characterization and anthelmintic activity
A Blinov, V Orobets, E Kastarnova, A Gvozdenko… - International Journal of …, 2024 - Elsevier
Synthesis, characterization and assessment of therapeutic efficacy of chitosan-
ricobendazole complex were carried out for the first time in this work. Study of physico …
ricobendazole complex were carried out for the first time in this work. Study of physico …
Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation
W Zhang, G Wang, E See, JP Shaw, BC Baguley… - Journal of controlled …, 2015 - Elsevier
The ultimate aim of this study was to develop asulacrine (ASL)-loaded long-circulating
liposomes to prevent phlebitis during intravenous (iv) infusion for chemotherapy. Poly …
liposomes to prevent phlebitis during intravenous (iv) infusion for chemotherapy. Poly …
Rectal Bioavailability of Amoxicillin from Hollow-Type Suppositories: Effect of Chemical Form of Amoxicillin
Rectal drug administration could offer advantages in the delivery of medicines for children
by avoiding swallowability issues, improving stability and enabling administration by …
by avoiding swallowability issues, improving stability and enabling administration by …
In-situ phase transition from microemulsion to liquid crystal with the potential of prolonged parenteral drug delivery
X Ren, D Svirskis, RG Alany, S Zargar-Shoshtari… - International journal of …, 2012 - Elsevier
This study is the first to investigate and demonstrate the potential of microemulsions (MEs)
for sustained release parenteral drug delivery, due to phase transition behavior in aqueous …
for sustained release parenteral drug delivery, due to phase transition behavior in aqueous …
Exploring the potential of flubendazole in filariasis control: evaluation of the systemic exposure for different pharmaceutical preparations
L Ceballos, C Mackenzie, T Geary… - PLoS neglected …, 2014 - journals.plos.org
The goal of elimination of the human filariases would benefit greatly from the use of a
macrofilaricidal agent. In vivo trials in humans and many experimental animal models …
macrofilaricidal agent. In vivo trials in humans and many experimental animal models …
Solving the delivery problems of triclabendazole using cyclodextrins
Triclabendazole is the first-line drug of choice to treat and control fasciolasis, a neglected
parasitic human disease. It is a class II/IV compound according to the Biopharmaceutics …
parasitic human disease. It is a class II/IV compound according to the Biopharmaceutics …